These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4083978

  • 21. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [Abstract] [Full Text] [Related]

  • 22. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H, Battelino T, Schober E, Baumgartner-Parzer S, Nowotny P, Vierhapper H.
    J Pediatr Endocrinol Metab; 2001 Nov; 14(9):1649-55. PubMed ID: 11795656
    [Abstract] [Full Text] [Related]

  • 23. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB.
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [Abstract] [Full Text] [Related]

  • 24. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [Abstract] [Full Text] [Related]

  • 25. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B, Roux H, Audi-Parera L, David M, Bertrand J.
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract] [Full Text] [Related]

  • 26. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
    Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.
    J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1797-1806. PubMed ID: 27845856
    [Abstract] [Full Text] [Related]

  • 27. [A case of congenital adrenogenital syndrome].
    Sumiya H, Kawamura K, Kataumi Z, Fuse H, Ito H, Shimazaki J.
    Hinyokika Kiyo; 1985 Aug 01; 31(8):1433-9. PubMed ID: 3878668
    [Abstract] [Full Text] [Related]

  • 28. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
    Horrocks PM, London DR.
    Clin Endocrinol (Oxf); 1982 Dec 01; 17(6):547-56. PubMed ID: 6299623
    [Abstract] [Full Text] [Related]

  • 29. [Successful treatment and pregnancy in a women with the non-classic form of congenital adrenal hyperplasia].
    van den Akker ES, Stikkelbroeck MM, Menheere PP, Roumen FJ, Otten BJ.
    Ned Tijdschr Geneeskd; 2002 Feb 09; 146(6):268-70. PubMed ID: 11865658
    [Abstract] [Full Text] [Related]

  • 30. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL.
    J Urol; 1999 Aug 09; 162(2):537-40. PubMed ID: 10411085
    [Abstract] [Full Text] [Related]

  • 31. Detection of late-onset 21-hydroxylase deficiency congenital adrenal hyperplasia in adolescents.
    Emans SJ, Grace E, Fleischnick E, Mansfield MJ, Crigler JF.
    Pediatrics; 1983 Nov 09; 72(5):690-5. PubMed ID: 6314235
    [Abstract] [Full Text] [Related]

  • 32. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
    Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 2000 Mar 09; 85(3):1114-20. PubMed ID: 10720048
    [Abstract] [Full Text] [Related]

  • 33. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency.
    Helleday J, Siwers B, Ritzén EM, Carlström K.
    J Clin Endocrinol Metab; 1993 Apr 09; 76(4):933-6. PubMed ID: 8473408
    [Abstract] [Full Text] [Related]

  • 34. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA, Read GF.
    Horm Res; 1984 Apr 09; 19(2):77-85. PubMed ID: 6538545
    [Abstract] [Full Text] [Related]

  • 35. [Adrenalectomy as therapy in refractory adrenogenital syndrome].
    von Mühlendahl KE, Sippell WG.
    Monatsschr Kinderheilkd; 1989 Jun 09; 137(6):341-4. PubMed ID: 2761548
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 17OH-progesterone response to acute dexamethasone administration in congenital adrenal hyperplasia.
    Shen SX, Young MC, Hinohosa-Sandoval M, Hughes IA.
    Horm Res; 1989 Jun 09; 32(4):136-41. PubMed ID: 2625323
    [Abstract] [Full Text] [Related]

  • 38. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S.
    J Clin Endocrinol Metab; 2007 Feb 09; 92(2):542-8. PubMed ID: 17148562
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.